Mupirocine Biogaran

Mupirocin, the active ingredient in Mupirocine Biogaran, is a topical antibiotic presented as a topical formulation for cutaneous use. It treats bacterial skin infections such as impetigo, infected cuts, abrasions and secondary infections of compromised skin, primarily in patients requiring localized antibacterial therapy.

GNH USA supplies Mupirocine Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocin is a topical antibacterial indicated for several skin infection conditions.

- Impetigo: reduces bacterial load and promotes healing of superficial lesions caused by Staphylococcus aureus or Streptococcus pyogenes. - Secondary bacterial infections of skin: treats colonisation of compromised skin, limiting spread and facilitating recovery. - Infected minor cuts, abrasions, or wounds: provides localized antibacterial action to prevent progression of infection.

Mupirocine Biogaran may cause local and systemic adverse reactions.

Common Side Effects: - Application site irritation: mild redness or discomfort at the site of use. - Burning sensation: transient heat feeling during or after application. - Itching: pruritus localized to the treated area. - Redness: erythema around the application site.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe skin reaction with swelling and vesicles. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare but life‑threatening skin detachment. - Systemic hypersensitivity: urticaria, angioedema, or anaphylaxis. - Mucosal involvement: ulceration or lesions on oral or genital mucosa.

Before using Mupirocine Biogaran, consider the following safety measures.

- Allergy assessment: verify no known hypersensitivity to mupirocin or related antibiotics. - Pregnancy and lactation: use only if the expected benefit outweighs potential risk; consult a healthcare professional. - Age considerations: safety not established in neonates younger than two months. - Extent of application: limit to affected area and avoid covering large skin surfaces or occlusion. - Concurrent skin conditions: avoid use on eczematous or dermatitis‑affected skin unless directed by a clinician. - Store at below 25°C: keep in the original container, protect from moisture and heat.

Mupirocine Biogaran may interact with other topical or systemic agents.

Major Interactions (Avoid): - Concurrent use with other topical antibiotics may increase the risk of local irritation or resistance development. - Use with systemic antibiotics that share the same mechanism may promote bacterial resistance.

Moderate Interactions (Monitor Closely): - Co‑application with corticosteroid creams may reduce antibacterial efficacy. - Use with wound dressings containing antiseptics may alter drug absorption. - Concurrent immunosuppressants may affect the host's ability to control infection.